LABTRACE.ORG BETA LIVE
240 source polls this hour 39 310 articles collected last article 1m ago 634 events on 2+ sources 0 embeddings/h feed queue 0 lag 382.0s
← all events
LT-013531 / first seen 2026-08-26 17:49 / last activity 15d ago solid / under-covered

Rituximab, Acalabrutinib, and Durvalumab for Primary Central Nervous System Lymphoma: A Single-Arm, Phase Ib, Multicenter Study

measurement

heat
12 / 100 (raw 0.2)
velocity
0.0 independent sources per hour
solidity
80 / 100
sources
1 total, 1 independent
domain span
1 domain covered it

primary source

title
Rituximab, Acalabrutinib, and Durvalumab for Primary Central Nervous System Lymphoma: A Single-Arm, Phase Ib, Multicenter Study
venue
status
peer-reviewed
doi
10.1158/1078-0432.ccr-25-3675
published
2026-04-22

media coverage / 1 outlets